On Friday shares of BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) closed at $9.65. Company’s sales growth for last 5 years was -28.90% and EPS growth for next 5 years is recorded as -14.70%. Analysts at Needham & Company LLC set a $15.00 price target on shares of BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) stock in a research report issued to clients and investors on Tuesday. The firm currently has a a “buy” rating on the stock. Needham & Company LLC’s price objective would suggest a potential upside of 66.11% from the stock’s previous close.

Cara Therapeutics Inc. (NASDAQ:CARA) in last trading activity increased 2.53% to close at $10.93. Company weekly performance is 8.86% while its quarterly performance stands at 4.39%. Cara Therapeutics Inc. (NASDAQ:CARA) is -40.50% away from its 52 week high. Cara Therapeutics Inc. (NASDAQ:CARA) announced that Dr. Derek Chalmers, President and CEO, will present a company overview at the 14th Annual Needham Healthcare Conference on Tuesday, April 14, 2015, at 3:00 p.m. ET in New York City.

Yingli Green Energy Holding Co. Ltd. (NYSE:YGE) has 5.32% insider ownership while its institutional ownership stands at 19.50%. In last trading activity company’s stock closed at $1.93.
On Apr 7, Yingli Green Energy Holding Co. Ltd. (NYSE:YGE) announced that it has supplied 15.5 megawatts (“MW”) of solar panels to a subsidiary of South Jersey Industries, Inc. Marina Energy. The company develops PV projects and provides engineering, procurement, and construction solutions.

On last trading day Arctic Cat Inc. (NASDAQ:ACAT) moved down -2.61% to close at $35.76. Its volatility for the week is 2.65% while volatility for the month is 3.02%. ACAT’s sales growth for past 5 years was 5.30% and its EPS growth for past 5 years was 49.50%. Arctic Cat Inc. (NASDAQ:ACAT) monthly performance is -4.05%. On 10 April, Arctic Cat Inc. (NASDAQ:ACAT) said that, it is planning to expand its ATV and snowmobile factory in Thief River Falls, Minn., provided it receives local tax subsidies it has requested.